

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.511, 2006-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Costs of Inflammatory Bowel Disease in Germany
By Stark Renee
PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. :


Costs of inflammatory bowel disease in the US substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :


Inflammatory Bowel Disease in the Elderly
Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. :


Macrophages in Inflammatory Bowel Disease
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :